Cargando…
Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151130/ https://www.ncbi.nlm.nih.gov/pubmed/37005558 http://dx.doi.org/10.1111/1759-7714.14877 |
| _version_ | 1785035472525852672 |
|---|---|
| author | Rizzo, Alessandro |
| author_facet | Rizzo, Alessandro |
| author_sort | Rizzo, Alessandro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10151130 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley & Sons Australia, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101511302023-05-02 Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer Rizzo, Alessandro Thorac Cancer Letter to the Editor John Wiley & Sons Australia, Ltd 2023-04-02 /pmc/articles/PMC10151130/ /pubmed/37005558 http://dx.doi.org/10.1111/1759-7714.14877 Text en © 2023 The Author. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Rizzo, Alessandro Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer |
| title | Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer |
| title_full | Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer |
| title_fullStr | Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer |
| title_full_unstemmed | Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer |
| title_short | Bayesian analysis supports the role of alectinib and ensartinib for ALK‐positive non–small cell lung cancer |
| title_sort | bayesian analysis supports the role of alectinib and ensartinib for alk‐positive non–small cell lung cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151130/ https://www.ncbi.nlm.nih.gov/pubmed/37005558 http://dx.doi.org/10.1111/1759-7714.14877 |
| work_keys_str_mv | AT rizzoalessandro bayesiananalysissupportstheroleofalectinibandensartinibforalkpositivenonsmallcelllungcancer |